Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical study
3
×
detroit blog main
detroit top stories
gene editing
glaxosmithkline
3
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
scott gottlieb
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
apremilast
celgene
commissioner
crispr
democrats
failure
fda
indiana blog main
indiana top stories
ipo
otezla
What
bio
roundup
crispr
abbvie’s
allogene
barbecuing
big
bosley's
bosley’s
bridge
bucks
camping
cancer
cardiologist
cas
center
ceo
check
cholesterol
conference
crime
day
departure
diversity
editas
exit
flop
guiding
hit
hot
immunotherapy
investors
ipo
j
juno
j’s
katrine
labor
medicine
million
Language
unset
Current search:
glaxosmithkline
×
" clinical study "
×
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More